Lewis Hamilton says that Ferrari’s performance at the Austin Grand Prix was ‘an amazing result’ after he and teammates Charles Leclerc finished fourth and third respectively. Despite underperforming in Saturday’s sprint race, the Prancing Horse found good pace during the Grand Prix with Hamilton moving up to fourth during the race on Sunday having overtaken
Continue Reading
All Analyst Report Argus • Oct 27, 2025 Equifax Inc.: Looking for more favorable entry point Summary Equifax is a global provider of information and credit reporting solutions for businesses, governments and consumers. Founded in 1899 as Retail Credit Company and based in Atlanta, the company has more than 15,000 e Upgrade to begin using
Continue Reading
CNN — A Florida man who served three decades behind bars for a murder he says he didn’t commit returned to prison Monday after spending the past two years building a life outside prison walls. Since his conditional release in 2021 amid appeals, Crosley Green, 65, had held a job at a machine grafting facility
Continue ReadingCNN — The family of a victim and several survivors of a mass shooting at a FedEx facility in Indianapolis filed a lawsuit against companies involved in the manufacturing, marketing and sale of the high capacity magazine used by the gunman who killed 8 people and injured several others in 2021. The federal lawsuit, filed
Continue Reading
” data-byline-html=”” data-byline-html=”” data-byline-html=”” data-byline-html=”
Continue Reading
Please upgrade your browser to view usatoday.com usatoday.com wants to ensure the best experience for all of our readers, so we built our site to take advantage of the latest technology, making it faster and easier to use. Unfortunately, your browser is not supported. Please download one of these browsers for the best experience on
Continue Reading
By Padmanabhan Ananthan and Angela Christy M (Reuters) -Swiss drugmaker Novartis on Sunday said it agreed to acquire U.S. biotech firm Avidity Biosciences for about $12 billion in cash, as the company looks to bolster its portfolio of treatments for rare muscle disorders. As per the terms of the deal, Avidity stockholders will receive $72
Continue Reading